Logo

... as Syngene Says Undisclosed Pharma Is Using Its Imaging Tech to Find Protein Targets

Jun 14, 2006

NEW YORK, June 14 (GenomeWeb News) - Syngene today said that an undisclosed "leading USpharmaceutical company" is using its imaging system to help it discover protein drug targets.

 

Researchers at this drug maker are using the technology to automatically assess around 150 2D protein gels per week. These gels are up to 26 cm x 26 cm and are stained with dyes including Sypro Orange, Sypro Ruby, Sybr Green, Coomassie Blue, and Pro-Q Diamond.

 

Financial terms of the deal were not disclosed.

Breaking News
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.